IDO2 and neoplasm: We classified the prognosis of 80 EOC patients into disease-free group (n = 55), tumor-bearing group (n = 16), and death group (n = 9), and compared the ratio of kynurenine to tryptophan (Kyn/Trp), which reflects indoleamine-2,3-dioxygenase (IDO) activity.